Experience of immune-related adverse events associated with ipilimumab and nivolumab in a single center.

Authors

Bernardo Rapoport

Bernardo Leon Rapoport

The Medical Oncology Centre of Rosebank, Johannesburg, South Africa

Bernardo Leon Rapoport, Teresa Smit, Ronwyn van Eeden

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Biomarkers and Inflammatory Signatures,Humoral Immunity for Diagnosis and Therapy,Immune Checkpoints and Stimulatory Receptors,Modulating Innate Immunity,Therapies Targeting T cells

Sub Track

Clinical Trials

Citation

J Clin Oncol 35, 2017 (suppl 7S; abstract 91)

DOI

10.1200/JCO.2017.35.7_suppl.91

Abstract #

91

Poster Bd #

D10

Abstract Disclosures